Huaren Pharmaceutical Co., Ltd.
Industry Group: Healthcare
Country/Region: China
Identifier: SHE:300110
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 617 out of 634
Universe
Global Universe 14116 out of 16006
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
STRATEC SE |
16.6
Low
|
72 out of 634 |
medmix AG |
27.8
Medium
|
379 out of 634 |
Zimvie, Inc. |
30
High
|
439 out of 634 |
IRadimed Corp. |
30.1
High
|
441 out of 634 |
Huaren Pharmaceutical Co., Ltd. |
36.6
High
|
617 out of 634 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Huaren Pharmaceutical Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Huaren Pharmaceutical Co., Ltd.'s Management of ESG Material Risk is Average